Results 81 to 90 of about 176 (130)

Publication Only

open access: yes
HemaSphere, Volume 10, Issue S1, June 2026.
wiley   +1 more source

Natural killer T lymphocyte like cells function and cytokine production interferon γ and interleukin 10 in chronic myelogenous leukemia: Implications for immune surveillance

open access: yesIraqi Journal of Hematology
BACKGROUND: Chronic myeloid leukemia (CML) is driven by the BCR-ABL1 oncogene (t(9;22)) and typically presents in a chronic phase (
Baan Abdulatif Mtashar   +1 more
doaj   +1 more source

BCR::ABL1-positive chronic myeloid leukaemia in a scenario of a remote diagnosis of JAK2-V617F-mutated polycythemia vera: a single patient experience with imatinib and ruxolitinib combination therapy

open access: yesAnnals of Hematology
We report the case of a 51-year-old male patient initially diagnosed with JAK2-V617F-mutated polycythemia vera (PV), who developed chronic phase BCR::ABL1-positive chronic myeloid leukemia (CML) 11 years later.
Paride Bartolucci   +7 more
doaj   +1 more source

Interferon-alpha 2a therapy in CML: disappearance of BCR/ABL transcript in a case of long-lasting continuous cytogenetic conversion

open access: yesHaematologica, 1994
Seventy months after diagnosis, minimal residual disease is undetectable in a patient with Philadelphia chromosome-positive chronic myelogenous leukemia (CML) in long-lasting continuous cytogenetic conversion (CCC), achieved through alpha 2a-interferon ...
S Pardini   +7 more
doaj  

Comparison of remission rates in Egyptian patients with chronic myeloid leukemia treated with different tyrosine kinase inhibitors below the age of fifty

open access: yesFamily Medicine & Primary Care Review
Mohamed Said Abd Elwahab   +4 more
doaj   +1 more source

Selective Induction of Apoptosis in Philadelphia Chromosome-Positive Chronic Myelogenous Leukemia Cells by an Inhibitor of BCR–ABL Tyrosine Kinase, CGP 57148 [PDF]

open access: yesCell Death and Differentiation, 1998
The BCR - ABL tyrosine kinase has been implicated as the cause of Philadelphia chromosome (Ph1)-positive leukemias. We report herein that CGP 57148, a selective inhibitor of the ABL tyrosine kinase, caused apoptosis specifically in bcr - abl-positive chronic myelogenous leukemia (CML) cells, K562 and KYO-1.
Shingo Dan, Takashi Tsuruo
exaly   +3 more sources

Nilotinib (Formerly AMN107), a Highly Selective BCR-ABL Tyrosine Kinase Inhibitor, Is Effective in Patients With Philadelphia Chromosome–Positive Chronic Myelogenous Leukemia in Chronic Phase Following Imatinib Resistance and Intolerance

open access: yesBlood, 2007
Abstract Nilotinib, an orally bioavailable, selective Bcr-Abl tyrosine kinase inhibitor, is 30-fold more potent than imatinib in pre-clinical models, and overcomes most imatinib resistant BCR-ABL mutations. In this phase 2 open-label study, 400 mg nilotinib was administered orally twice daily to 280 patients with Philadelphia ...
Kapil Bhalla   +2 more
exaly   +5 more sources

Cytogenetic response to autografting in chronic myelogenous leukemia correlates with the amount of BCR-ABL positive cells in the graft

Experimental Hematology, 2000
An important step in successful autografting of patients with chronic myelogenous leukemia is the delivery of a leukemia-free graft. We conducted this study to determine whether the cytogenetic response after autografting was correlated with the number of BCR ABL-positive cells present within the stem cell grafts.By BCR-ABL mRNA quantification, we ...
M T, Corsetti   +12 more
openaire   +2 more sources

Flow cytometric assay of phosphotyrosine levels in Bcr-Abl-positive chronic myelogenous leukemias: a potential prognostic marker

Annals of Hematology, 2008
Assay of phosphotyrosine levels using flow cytometry has been used to identify patients with chronic myelogenous leukemia positive for the Bcr-Abl fusion gene. We hypothesized that clinical monitoring could identify treatment response through reductions in intragranulocyte phosphotyrosine.
Xuemei, Sun   +9 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy